- Home
- BWEN vs FGEN Comparison
BWEN vs FGEN Comparison
Compare BWEN & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- FGEN
- Stock Information
- Founded
- BWEN N/A
- FGEN 1993
- Country
- BWEN United States
- FGEN United States
- Employees
- BWEN N/A
- FGEN N/A
- Industry
- BWEN Industrial Machinery/Components
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- BWEN Industrials
- FGEN Health Care
- Exchange
- BWEN Nasdaq
- FGEN Nasdaq
- Market Cap
- BWEN 39.1M
- FGEN 34.5M
- IPO Year
- BWEN N/A
- FGEN 2014
- Fundamental
- Price
- BWEN $1.85
- FGEN $0.40
- Analyst Decision
- BWEN Strong Buy
- FGEN
- Analyst Count
- BWEN 3
- FGEN 0
- Target Price
- BWEN $5.17
- FGEN N/A
- AVG Volume (30 Days)
- BWEN 153.1K
- FGEN 996.1K
- Earning Date
- BWEN 11-13-2024
- FGEN 11-12-2024
- Dividend Yield
- BWEN N/A
- FGEN N/A
- EPS Growth
- BWEN N/A
- FGEN N/A
- EPS
- BWEN 0.14
- FGEN N/A
- Revenue
- BWEN $156,169,000.00
- FGEN $180,015,000.00
- Revenue This Year
- BWEN N/A
- FGEN $19.67
- Revenue Next Year
- BWEN $25.42
- FGEN N/A
- P/E Ratio
- BWEN $13.21
- FGEN N/A
- Revenue Growth
- BWEN N/A
- FGEN 16.15
- 52 Week Low
- BWEN $1.52
- FGEN $0.18
- 52 Week High
- BWEN $4.65
- FGEN $2.93
- Technical
- Relative Strength Index (RSI)
- BWEN 53.51
- FGEN 58.65
- Support Level
- BWEN $1.74
- FGEN $0.34
- Resistance Level
- BWEN $1.87
- FGEN $0.37
- Average True Range (ATR)
- BWEN 0.10
- FGEN 0.04
- MACD
- BWEN 0.01
- FGEN -0.00
- Stochastic Oscillator
- BWEN 37.93
- FGEN 76.07
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through three operating segments namely Heavy Fabrications, Gearing and Industrial Solutions.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.